Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Major decreases in the lipidome following liraglutide treatment: 21-25 September 2020.

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  1. The Rac2 GTPase contributes to cathepsin H-mediated protection against cytokine-induced apoptosis in insulin-secreting cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long Noncoding RNAs in Diabetes and β-Cell Regulation

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

Vis graf over relationer

Aims/hypothesis. Beta cell loss in Type 1 and Type 2 diabetes mellitus may result from apoptosis and necrosis induced by inflammatory mediators. The suppressor of cytokine signalling (SOCS)-3 is a natural inhibitor of cytokine signalling and also influences insulin signalling. SOCS3 could therefore be a candidate gene in the development of Type 1 and Type 2 diabetes mellitus. Methods. Mutation analysis of the SOCS3 gene was performed in 21 patients with Type 1 diabetes mellitus and in seven healthy subjects. An identified promoter variant was examined in (i) 250 families with Type 1 diabetic family members (1097 individuals); (ii) 212 glucose-tolerant first-degree relatives of Type 2 diabetic patients; and (iii) 370 population-based young, healthy subjects who were unrelated. Results. Three mutations were identified in the promoter region, but none in the coding region or the 3′UTR. Two of the three mutations had allele frequencies below 1% whereas the C -920→A substitution had a minor allele frequency of 8%. In the group of young healthy subjects the insulin sensitivity index was higher among homozygous carriers of the A-allele than among heterozygous and wild-type subjects (p=0.027, uncorrected). The same trend was found in the group of first-degree relatives of Type 2 diabetic patients. No association or linkage was found to Type 1 diabetes mellitus. Conclusions/interpretation, Homozygosity for the A-allele of the C -920→A promoter polymorphism of the SOCS3 gene may be associated with increased whole-body insulin sensitivity, but deserves further investigation.

OriginalsprogEngelsk
TidsskriftDiabetologia
Vol/bind47
Udgave nummer7
Sider (fra-til)1273-1277
Antal sider5
ISSN0012-186X
DOI
StatusUdgivet - 1 jan. 2004

ID: 56664540